|
Presentations by Steven K. Galson, M.D., MPH
CDER Center Director
2007
- CDER Update, WCBP, January 29, 2007 [PDF]
- Prescription Drug Use Fee Act (PDUFA IV), Public Meeting, February 16, 2007 [PDF]
- FDA Response to the IOM Report, College of Preventative Medicine, February 24, 2007 [PDF]
2006
- CDER Update (2005), Stanford Washington Research Group, January 17, 2006 [PDF]
- CDER Update (2006), Stanford Washington Research Group, January 18, 2006 [PDF]
- What's New in CDER, ORA San Francisco District Office, January 23, 2006 [PDF]
- Drug Regulation Update, 10th Annual Symposium on the Inerface of Regulatory & Analytical Sciences for Biotechnology Health Products, January 24, 2006 [PDF]
- FDA Drug Approval: Ensuring Patient Safety and Access in Today's Fast-Changing World of Pharmaceuticals, Howard University, February 8, 2006 [PDF]
- Controversy in Drug Regulation: Ensuring Patient Safety and Access, Mount Sinai School of Medicine, March 2, 2006 [PDF]
- CDER Update, Lehman Brothers 9th Annual Global Healthcare Conference, March 10, 2006 [PDF]
- FDA/Industry Conference, Temple University School of Medicine, March 29, 2006 [PDF]
- CDER Breakout Session, FDLI 49th Annual Conference, April 7, 2006 [PDF]
- Opportunities in Personalized Medicine, Science Forum, Douglas C. Throckmorton, M.D., April 16, 2006 [PDF]
- The Changing Regulatory Climate: FDA Perspective, Post-Approval Summit at Harvard, May 8, 2006 [PDF]
- OMB Proposed Risk Assessment Bulletin and its Potential Impact on FDA, National Academy of Sciences Meeting, May 22, 2006 [PDF]
- Unique Challenges for Pharmaceuticals, Institute of Medicine, May 30, 2006 [PDF]
- Understanding the Benefits and Risks of Pharmaceuticals: Opening Remarks, Institute of Medicine, May 30-31, 2006 [PDF]
- Disscussion Slides, Institute of Medicine, May 30-31, 2006 [PDF]
- Drug Regulation - 2006 Chemical Heritage Foundation Philadelphia, May 16, 2006 [PDF]
- Drug Safety 2006: What You Need to Know, Financial Women's Association, June 12, 2006 [PDF]
- CDER Office of Management and Budget Visit, August 8, 2006 [PDF]
- CDER U.S. House Appropriations Briefing, August 30, 2006 [PDF]
- Drug Approvals for 2005, Healthcare Innovations, September 12-13, 2006 [PDF]
- State of CDER, October 4, 2006 [PDF]
- Center Director's Update, GPhA Technical Conference, October 18, 2006 [PDF]
- Presentation to the American Public Health Association, November 6, 2006 [PDF]
- CDER Overview, Harvard University, November 7, 2006 [PDF]
- CDER Update, Johnson and Johnson, November 14, 2006 [PDF]
- Critical Path and Drug Safety: Progress and Updates, PhRMA Conclave, November 30, 2005
- FDA Drug Approval: Ensuring Patient Safety and Access in Today's Fast-Changing World of Pharmaceuticals, National Health Council, December 2, 2006 [PDF]
- CDER Update, Windhover FDA/CMS Summit, December 4, 2006 [PDF]
2005
- The Future of Drug Development and Regulation in the United States, Piper Jaffray 17th Annual Healthcare Conference, January 26, 2005 [PDF]
- Current Issues in Drug Regulation at FDA, February 2, 2005 [PDF]
- Program Background and Preparation for FY 2006 Appropriations Hearings, February 11, 2006 [PDF]
- Current Issues in CDER, Generic Pharmaceutical Association, February 25, 2005 [PDF]
- Drug Safety in Controversy: FDA Actions, Johns Hopkins Boomberg School of Public Health, March 15, 2005 [PDF]
- Setting Drug Specifications in the 21st Century, PQRI Workshop, March 16, 2005 [PDF]
- Drug Safety Initiative: FDA Science Board, April 15, 2005 [PDF]
- Controversies in Drug Regulation, Oregon Health Resources Commission, April 21, 2005 [PDF]
- Changes to Enhance Customer Needs, FDA Science Board, April 27, 2005 [PDF]
- Current Issues in Drug Regulation at FDA, Sigma Xi, May 6, 2005 [PDF]
- Controversies in Drug Regulation, Health Communications Research Center at the Missouri School of Journalism and the Missouri Arthritis Rehabilitation Research and Training Center, May 12, 2005 [PDF]
- Committee on the Assessment of the U.S. Drug Safety System: Charge to the Committee, National Academeies Institute of Medicine, June 8, 2005 [PDF]
- Issues in Drug Regulation, Marwood Group, June 28, 2005 [PDF]
- Issues in Drug Regulation, National Venture Capital Association, September 27, 2005 [PDF]
- PhRMA Drug Safety Panel for Patient Advocates, September 28, 2005 [PDF]
- Challenges and Opportunities in Drug Development and Manufacturing, CMC Workshop, October 7, 2005 [PDF]
- A New Era of Regulatory Progress, GPhA Fall Technical Conference, October 24, 2005 [PDF]
- CDER Drug Safety Update, FDA Science Board, November 6, 2005 [PDF]
- PDUFA IV Public Meeting, November 14, 2005 [PDF]
- Critical Path and Drug Safety: Progress and Updates, PhRMA Conclave, November 30, 2005 [PDF]
- FDA Drug Approval: Ensuring Patient Safety and Access in Today's Fast-Changing World of Pharmaceuticals, December 2, 2005 [PDF]
- Drug Safety in the U.S.: Patient Safety and Access in Today's Fast-Changing World of Phamaceuticals, American Public Health Association, December 14, 2005 [PDF]
Back
to Top
Back to Presentations
PDF requires the free Adobe Acrobat Reader
Date created: February 28, 2007; updated March 12, 2007 |
|